Related Experiment Video

Updated: Jul 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Epidemiology and clinical characteristics of childhood parapneumonic empyemas]

A Desrumaux1, P François, C Pascal

  • 1Département de pédiatrie, CHU de Grenoble, 38043 Grenoble, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|July 17, 2007
PubMed

Insights

The incidence of complicated childhood pneumonia, including parapneumonic empyema, significantly increased in a French region from 1995 to 2003. Further research is needed to determine the causes of this rise in pediatric cases.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Epidemiology

Context:

  • Childhood parapneumonic empyema incidence is rising globally.
  • Community-acquired pneumonia (CAP) can lead to severe complications in children.
  • Understanding regional trends in pediatric CAP complications is crucial for public health.

Purpose:

  • To estimate the annual incidence of complicated CAP in children in a French region over nine years (1995-2003).
  • To describe the epidemiological and clinical features of these pediatric pneumonia complications.
  • To identify trends in childhood empyema and lung abscess hospitalizations.

Summary:

  • A 9-year study (1995-2003) in the Isere district, France, analyzed 90 hospitalizations for complicated CAP in children (28 days to 15 years).
  • Complications included 83 pleural empyemas and 7 lung abscesses.
  • The incidence of complicated pneumonia rose from 0.5 to 13 per 100,000 children, with a significant increase noted since 1999 (P<0.001).

Impact:

  • This study highlights a significant increase in complicated pediatric pneumonia in France, necessitating further investigation into causative factors.
  • Findings underscore the importance of monitoring pediatric respiratory infections and their complications.
  • The data provides valuable epidemiological insights for pediatric pulmonologists and public health officials.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.